Haloperidol Injection
Product Images NDC 0143-9502

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 0143-9502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Haloperidol Injection Usp 1)

Structural Formula (Haloperidol Injection Usp 1)
Chemical structure of Haloperidol Lactate, showing its molecular configuration with chlorine, hydroxyl, fluorophenyl, and piperidine components.*
FDA Label Image

Haloperidol Injection, Usp 5 mg/ml Vial Label (Haloperidol Injection Usp 2)

Haloperidol Injection, Usp 5 mg/ml Vial Label (Haloperidol Injection Usp 2)
Label for Haloperidol Injection, USP 5 mg/mL, an intramuscular injection in a 1 mL single-dose vial. The label states it is for intramuscular use only and includes storage instructions, lot number, and expiration date fields. The product is labeled by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Haloperidol Injection, Usp 50 mg/10 mL Vial Label (Haloperidol Injection Usp 3)

Haloperidol Injection, Usp 50 mg/10 mL Vial Label (Haloperidol Injection Usp 3)
Haloperidol Injection, USP 5 mg per 10 mL (5 mg/mL) intramuscular injection label from Hikma Pharmaceuticals USA Inc. The label states this is for immediate release and a 10 mL sterile multiple-dose vial. It includes storage instructions (20° to 25°C) and lists haloperidol lactate as the active ingredient along with preservatives methylparaben and propylparaben.*
FDA Label Image

Haloperidol Injection Usp 4

Haloperidol Injection Usp 4
Haloperidol Injection, USP 5 mg/mL single dose vial label for intramuscular use only. The label states it is for immediate release and contains 25 vials of 1 mL each. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Storage instructions specify 20 to 25°C and protection from light.*
FDA Label Image

Haloperidol Injection Usp 5

Haloperidol Injection Usp 5
Packaging label for Haloperidol Injection, USP (5 mg/mL) by Hikma Pharmaceuticals USA Inc. The label states 50 mg per 10 mL, for intramuscular use only, in a 10 mL sterile multiple dose vial. It includes storage instructions at 20° to 25°C, preservation details, and manufacturer information with a barcode.*
FDA Label Image

Haloperidol Injection Usp 6

Haloperidol Injection Usp 6
A label featuring a QR code on the left side with alphanumeric text on the right. The text includes GTIN, serial number (SN), expiration date (EXP), and lot number (LOT) information, displayed in a simple black font on a white background. This label likely pertains to Haloperidol Lactate 5 mg/mL intramuscular injection by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.